Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-187542
Filing Date
2024-07-29
Accepted
2024-07-29 16:01:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5589
  Complete submission text file 0001193125-24-187542.txt   6668
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)